Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
Abbott Laboratories, the maker of the popular infant formula Similac, will pay nearly $385 million to settle claims that it knowingly sold formula manufactured in facilities that did not meet safety requirements.
Simplified Text
Abbott Laboratories will pay nearly $385 million to settle claims of selling formula from facilities that did not meet safety requirements.
Confidence Score
1.000
Claim Maker
The author
Context Type
News Article
Context Details
{
    "date": "2026-09-14",
    "company": "Abbott Laboratories",
    "product": "Similac",
    "announcing_body": "Justice Department",
    "settlement_amount": "~$385 million"
}
UUID
19d6b547-8717-4b41-acf0-f6a224981e40
Vector Index
âś— No vector
Created
September 18, 2026 at 2:01 AM (3 weeks ago)
Last Updated
September 18, 2026 at 2:01 AM (3 weeks ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://nytimes.com/2026/09/14/well/abbott-settlement-infant-formula.html
12 claims 🔥
3 weeks ago
https://nytimes.com/2026/09/14/well/abbott-settlement-infant-formula.html

Abbott Laboratories will pay nearly $385 million to settle claims that it knowingly sold infant formula manufactured in facilities that did not meet safety requirements. This follows a 2022 recall linked to serious illnesses in babies and a nationwide formula shortage.

Similar Claims (5)

Other claims identified as semantically similar to this one.